About
This skill integrates the Open Targets Platform's vast dataset into Claude's workflow, enabling systematic identification and prioritization of potential drug targets. It provides programmatic access to the Open Targets GraphQL API, allowing users to evaluate target tractability, safety, and clinical precedence while gathering evidence from human genetics, pathways, and literature. It is an essential tool for computational biologists and pharmaceutical researchers performing target discovery, drug repurposing, or competitive intelligence.